Mikhail Levit - Concepedia

Author

Mikhail Levit

Sanofi (United States)ORCID

Also Known As

M Levit, M. N. Levit, Mikhail Levit, Mikhail N Levit, Mikhail N. Levit, Y Zheng

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Sanofi (United States)Princeton University Sanofi (France)AVEO Oncology (United States)Sanofi (Germany)

About

Mikhail Levit is an author at Sanofi (United States) specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	317
2	Natural Sciences	2	2	141
3	Biochemistry	2	2	141
4	Cell Biology	2	2	166
5	Engineering	1	1	22

Mikhail Levit

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models C. Hotz, Timothy R. Wagenaar, Friederike Gieseke, Science Translational Medicine	2021	187
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells Edward Seung, Zhen Xing, Lan Wu, Nature Trispecific AntibodyBreast Cancer GrowthBreast OncologyImmunologyAntigen Processing	2022	144
Dimerization Is Required for the Activity of the Protein Histidine Kinase CheA That Mediates Signal Transduction in Bacterial Chemotaxis Michael G. Surette, Mikhail Levit, Yi Liu, Journal of Biological Chemistry Prokaryotic SystemSignal TransductionBiochemistryNatural SciencesBacteriology	1996	131
Receptor Methylation Controls the Magnitude of Stimulus-Response Coupling in Bacterial Chemotaxis Mikhail Levit, Jeffry B. Stock Journal of Biological Chemistry	2002	96
Catalysis of DNA cleavage and nucleoside triphosphate synthesis by NM23-H2/NDP kinase share an active site that implies a DNA repair function Edith H. Postel, Bozena M. Abramczyk, Mikhail Levit, Proceedings of the National Academy of Sciences	2000	93
Organization of the Receptor-Kinase Signaling Array That Regulates Escherichia coli Chemotaxis Mikhail Levit, Thorsten Grebe, Jeffry B. Stock Journal of Biological Chemistry	2002	86
Discovery of 6-(2,4-Dichlorophenyl)-5-[4-[(3<i>S</i>)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7<i>H</i>-benzo[7]annulene-2-carboxylic acid (SAR439859), a Potent and Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen-Receptor-Positive Breast Cancer Youssef El‐Ahmad, Michel Tabart, Frank Halley, Journal of Medicinal Chemistry	2019	80
Active Site Interference and Asymmetric Activation in the Chemotaxis Protein Histidine Kinase CheA Mikhail Levit, Yi Liu, Michael G. Surette, Journal of Biological Chemistry	1996	67
SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), Demonstrates Effective and Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models Maysoun Shomali, Jane Cheng, Fangxian Sun, Molecular Cancer Therapeutics	2020	66
Interactions between Escherichia coliNucleoside-diphosphate Kinase and DNA Mikhail Levit, Bozena M. Abramczyk, Jeffry B. Stock, Journal of Biological Chemistry	2002	53

Page 1